The global Antiviral Drugs market was valued at US$ 1591.9 million in 2023 and is anticipated to reach US$ 2223.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Antiviral Drugs Market

Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.

In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.

This report aims to provide a comprehensive presentation of the global market for Antiviral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drugs.

Report Scope

The Antiviral Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiviral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antiviral Drugs Market Report

Report Metric	Details
Report Name	Antiviral Drugs Market
Accounted market size in 2023	US$ 1591.9 million
Forecasted market size in 2030	US$ 2223.5 million
CAGR	4.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Reverse Transcriptase Inhibitors Protease Inhibitors Fusion Inhibitors Immune System Modulators
Segment by Application	Hepatitis Therapeutics HIV/AIDS Therapeutics Herpes Therapeutics Influenza Therapeutics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, AbbVie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiviral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiviral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antiviral Drugs Market growing?

Ans: The Antiviral Drugs Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Antiviral Drugs Market size in 2030?

Ans: The Antiviral Drugs Market size in 2030 will be US$ 2223.5 million.

Who are the main players in the Antiviral Drugs Market report?

Ans: The main players in the Antiviral Drugs Market are Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, AbbVie

What are the Application segmentation covered in the Antiviral Drugs Market report?

Ans: The Applications covered in the Antiviral Drugs Market report are Hepatitis Therapeutics, HIV/AIDS Therapeutics, Herpes Therapeutics, Influenza Therapeutics

What are the Type segmentation covered in the Antiviral Drugs Market report?

Ans: The Types covered in the Antiviral Drugs Market report are Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System Modulators

1 Antiviral Drugs Market Overview

1.1 Product Overview and Scope of Antiviral Drugs

1.2 Antiviral Drugs Segment by Type

1.2.1 Global Antiviral Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Reverse Transcriptase Inhibitors

1.2.3 Protease Inhibitors

1.2.4 Fusion Inhibitors

1.2.5 Immune System Modulators

1.3 Antiviral Drugs Segment by Application

1.3.1 Global Antiviral Drugs Market Value by Application: (2024-2030)

1.3.2 Hepatitis Therapeutics

1.3.3 HIV/AIDS Therapeutics

1.3.4 Herpes Therapeutics

1.3.5 Influenza Therapeutics

1.4 Global Antiviral Drugs Market Size Estimates and Forecasts

1.4.1 Global Antiviral Drugs Revenue 2019-2030

1.4.2 Global Antiviral Drugs Sales 2019-2030

1.4.3 Global Antiviral Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Antiviral Drugs Market Competition by Manufacturers

2.1 Global Antiviral Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Antiviral Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Antiviral Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Antiviral Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antiviral Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antiviral Drugs, Product Type & Application

2.7 Antiviral Drugs Market Competitive Situation and Trends

2.7.1 Antiviral Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Antiviral Drugs Players Market Share by Revenue

2.7.3 Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antiviral Drugs Retrospective Market Scenario by Region

3.1 Global Antiviral Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Antiviral Drugs Global Antiviral Drugs Sales by Region: 2019-2030

3.2.1 Global Antiviral Drugs Sales by Region: 2019-2024

3.2.2 Global Antiviral Drugs Sales by Region: 2025-2030

3.3 Global Antiviral Drugs Global Antiviral Drugs Revenue by Region: 2019-2030

3.3.1 Global Antiviral Drugs Revenue by Region: 2019-2024

3.3.2 Global Antiviral Drugs Revenue by Region: 2025-2030

3.4 North America Antiviral Drugs Market Facts & Figures by Country

3.4.1 North America Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Antiviral Drugs Sales by Country (2019-2030)

3.4.3 North America Antiviral Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Antiviral Drugs Market Facts & Figures by Country

3.5.1 Europe Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Antiviral Drugs Sales by Country (2019-2030)

3.5.3 Europe Antiviral Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antiviral Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Antiviral Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Antiviral Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Antiviral Drugs Market Facts & Figures by Country

3.7.1 Latin America Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Antiviral Drugs Sales by Country (2019-2030)

3.7.3 Latin America Antiviral Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antiviral Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Antiviral Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Antiviral Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Antiviral Drugs Sales by Type (2019-2030)

4.1.1 Global Antiviral Drugs Sales by Type (2019-2024)

4.1.2 Global Antiviral Drugs Sales by Type (2025-2030)

4.1.3 Global Antiviral Drugs Sales Market Share by Type (2019-2030)

4.2 Global Antiviral Drugs Revenue by Type (2019-2030)

4.2.1 Global Antiviral Drugs Revenue by Type (2019-2024)

4.2.2 Global Antiviral Drugs Revenue by Type (2025-2030)

4.2.3 Global Antiviral Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Antiviral Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Antiviral Drugs Sales by Application (2019-2030)

5.1.1 Global Antiviral Drugs Sales by Application (2019-2024)

5.1.2 Global Antiviral Drugs Sales by Application (2025-2030)

5.1.3 Global Antiviral Drugs Sales Market Share by Application (2019-2030)

5.2 Global Antiviral Drugs Revenue by Application (2019-2030)

5.2.1 Global Antiviral Drugs Revenue by Application (2019-2024)

5.2.2 Global Antiviral Drugs Revenue by Application (2025-2030)

5.2.3 Global Antiviral Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Antiviral Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Roche Antiviral Drugs Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Johnson & Johnson Antiviral Drugs Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Merck

6.3.1 Merck Corporation Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Merck Antiviral Drugs Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Antiviral Drugs Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Bristol-Myers Squibb

6.5.1 Bristol-Myers Squibb Corporation Information

6.5.2 Bristol-Myers Squibb Description and Business Overview

6.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bristol-Myers Squibb Antiviral Drugs Product Portfolio

6.5.5 Bristol-Myers Squibb Recent Developments/Updates

6.6 Gilead Sciences

6.6.1 Gilead Sciences Corporation Information

6.6.2 Gilead Sciences Description and Business Overview

6.6.3 Gilead Sciences Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Gilead Sciences Antiviral Drugs Product Portfolio

6.6.5 Gilead Sciences Recent Developments/Updates

6.7 GlaxoSmithKline

6.6.1 GlaxoSmithKline Corporation Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Antiviral Drugs Product Portfolio

6.7.5 GlaxoSmithKline Recent Developments/Updates

6.8 AbbVie

6.8.1 AbbVie Corporation Information

6.8.2 AbbVie Description and Business Overview

6.8.3 AbbVie Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 AbbVie Antiviral Drugs Product Portfolio

6.8.5 AbbVie Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antiviral Drugs Industry Chain Analysis

7.2 Antiviral Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antiviral Drugs Production Mode & Process

7.4 Antiviral Drugs Sales and Marketing

7.4.1 Antiviral Drugs Sales Channels

7.4.2 Antiviral Drugs Distributors

7.5 Antiviral Drugs Customers

8 Antiviral Drugs Market Dynamics

8.1 Antiviral Drugs Industry Trends

8.2 Antiviral Drugs Market Drivers

8.3 Antiviral Drugs Market Challenges

8.4 Antiviral Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Antiviral Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Antiviral Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Antiviral Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Antiviral Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Antiviral Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Antiviral Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Antiviral Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Antiviral Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Antiviral Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antiviral Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antiviral Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Antiviral Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antiviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiviral Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Antiviral Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Antiviral Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Antiviral Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Antiviral Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Antiviral Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Antiviral Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Antiviral Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Antiviral Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Antiviral Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Antiviral Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Antiviral Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Antiviral Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Antiviral Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Antiviral Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Antiviral Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Antiviral Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Antiviral Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Antiviral Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Antiviral Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Antiviral Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Antiviral Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Antiviral Drugs Price (USD/Unit) by Type (2019-2024)

Table 59. Global Antiviral Drugs Price (USD/Unit) by Type (2025-2030)

Table 60. Global Antiviral Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Antiviral Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Antiviral Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Antiviral Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Antiviral Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Antiviral Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Antiviral Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Antiviral Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Antiviral Drugs Price (USD/Unit) by Application (2019-2024)

Table 69. Global Antiviral Drugs Price (USD/Unit) by Application (2025-2030)

Table 70. Roche Corporation Information

Table 71. Roche Description and Business Overview

Table 72. Roche Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Roche Antiviral Drugs Product

Table 74. Roche Recent Developments/Updates

Table 75. Johnson & Johnson Corporation Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Johnson & Johnson Antiviral Drugs Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Merck Corporation Information

Table 81. Merck Description and Business Overview

Table 82. Merck Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Merck Antiviral Drugs Product

Table 84. Merck Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Novartis Antiviral Drugs Product

Table 89. Novartis Recent Developments/Updates

Table 90. Bristol-Myers Squibb Corporation Information

Table 91. Bristol-Myers Squibb Description and Business Overview

Table 92. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Bristol-Myers Squibb Antiviral Drugs Product

Table 94. Bristol-Myers Squibb Recent Developments/Updates

Table 95. Gilead Sciences Corporation Information

Table 96. Gilead Sciences Description and Business Overview

Table 97. Gilead Sciences Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Gilead Sciences Antiviral Drugs Product

Table 99. Gilead Sciences Recent Developments/Updates

Table 100. GlaxoSmithKline Corporation Information

Table 101. GlaxoSmithKline Description and Business Overview

Table 102. GlaxoSmithKline Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. GlaxoSmithKline Antiviral Drugs Product

Table 104. GlaxoSmithKline Recent Developments/Updates

Table 105. AbbVie Corporation Information

Table 106. AbbVie Description and Business Overview

Table 107. AbbVie Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. AbbVie Antiviral Drugs Product

Table 109. AbbVie Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Antiviral Drugs Distributors List

Table 113. Antiviral Drugs Customers List

Table 114. Antiviral Drugs Market Trends

Table 115. Antiviral Drugs Market Drivers

Table 116. Antiviral Drugs Market Challenges

Table 117. Antiviral Drugs Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Antiviral Drugs

Figure 2. Global Antiviral Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antiviral Drugs Market Share by Type in 2023 & 2030

Figure 4. Reverse Transcriptase Inhibitors Product Picture

Figure 5. Protease Inhibitors Product Picture

Figure 6. Fusion Inhibitors Product Picture

Figure 7. Immune System Modulators Product Picture

Figure 8. Global Antiviral Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Antiviral Drugs Market Share by Application in 2023 & 2030

Figure 10. Hepatitis Therapeutics

Figure 11. HIV/AIDS Therapeutics

Figure 12. Herpes Therapeutics

Figure 13. Influenza Therapeutics

Figure 14. Global Antiviral Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Antiviral Drugs Market Size (2019-2030) & (US$ Million)

Figure 16. Global Antiviral Drugs Sales (2019-2030) & (K Units)

Figure 17. Global Antiviral Drugs Average Price (USD/Unit) & (2019-2030)

Figure 18. Antiviral Drugs Report Years Considered

Figure 19. Antiviral Drugs Sales Share by Manufacturers in 2023

Figure 20. Global Antiviral Drugs Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Antiviral Drugs Players: Market Share by Revenue in 2023

Figure 22. Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Antiviral Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Antiviral Drugs Sales Market Share by Country (2019-2030)

Figure 25. North America Antiviral Drugs Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Antiviral Drugs Sales Market Share by Country (2019-2030)

Figure 29. Europe Antiviral Drugs Revenue Market Share by Country (2019-2030)

Figure 30. Germany Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Antiviral Drugs Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Antiviral Drugs Revenue Market Share by Region (2019-2030)

Figure 37. China Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Antiviral Drugs Sales Market Share by Country (2019-2030)

Figure 48. Latin America Antiviral Drugs Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Antiviral Drugs Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Antiviral Drugs Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. U.A.E Antiviral Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Antiviral Drugs by Type (2019-2030)

Figure 58. Global Revenue Market Share of Antiviral Drugs by Type (2019-2030)

Figure 59. Global Antiviral Drugs Price (USD/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Antiviral Drugs by Application (2019-2030)

Figure 61. Global Revenue Market Share of Antiviral Drugs by Application (2019-2030)

Figure 62. Global Antiviral Drugs Price (USD/Unit) by Application (2019-2030)

Figure 63. Antiviral Drugs Value Chain

Figure 64. Antiviral Drugs Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Influenza Diagnostics Market

Protease Inhibitors Market

Hepatitis B Therapeutics Market

Anti Viral Coatings Market

Sterile and Antiviral Packaging Market

Specific Antiviral Drugs for COVID 19 Market

Novel Antiviral Drugs Market

Direct acting Antiviral Drugs Market

Influenza Antiviral Drugs Market

Antiviral Therapy Market

HIV Therapeutics Market

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions